1. Quality of Life in the Chronic GVHD Consortium Cohort: Lessons Learned and the Long Road Ahead

   • Christa Krupski
   • Madan Jagasia

   Health Economics (N Khera, Section Editor) 25 August 2015 Pages: 183 - 191

   

2. Persistent Disparities in Adult Hematopoietic Cell Transplantation

   • David G. Crockett
   • Fausto R. Loberiza Jr

   Health Economics (N Khera, Section Editor) 24 June 2015 Pages: 192 - 198

3. Optimizing Quality and Efficiency of Healthcare Delivery in Hematopoietic Cell Transplantation

   • Navneet S Majhail

   Health Economics (N Khera, Section Editor) 24 May 2015 Pages: 199 - 204

   

4. Financial Hardship—an Unwanted Consequence of Cancer Treatment

   • Julie McNulty
   • Nandita Khera

   Health Economics (N Khera, Section Editor) 26 June 2015 Pages: 205 - 212

   

5. The Value of Patient Reported Outcomes and Other Patient-Generated Health Data in Clinical Hematology

   • Hemant S. Murthy
   • William A. Wood

   Health Economics (N Khera, Section Editor) 04 June 2015 Pages: 213 - 224

   

6. A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies

   • Marlise R. Luskin
   • Rahul Banerjee
   • Alison W. Loren

   Health Economics (N Khera, Section Editor) 11 July 2015 Pages: 225 - 236

7. Non-Hodgkin Lymphoma in Children

   • John T. Sandlund

   B-cell NHL, T-cell NHL and Hodgkin Lymphoma (J Armitage, Section Editor) 15 July 2015 Pages: 237 - 243

   

8. To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes

   • Jean L. Koff
   • Dai Chihara
   • Christopher R. Flowers

   B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Armitage, Section Editor) 24 June 2015 Pages: 244 - 255

   

9. The GHSG Approach to Treating Hodgkin’s Lymphoma

   • Paul J. Bröckelmann
   • Andreas Engert

   B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Armitage, Section Editor) 30 May 2015 Pages: 256 - 265

   

10. Treating Burkitt Lymphoma in Adults

    • Carla Casulo
    • Jonathan Friedberg

    B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Armitage, Section Editor) 27 May 2015 Pages: 266 - 271

    

11. Incidence and Burden of the Myelodysplastic Syndromes

    • Christopher R. Cogle

    Myelodysplastic Syndromes (D Steensma, Section Editor) Open access 02 July 2015 Pages: 272 - 281

12. Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?

    • Rafael Bejar

    Myelodysplastic Syndromes (D Steensma, Section Editor) Open access 01 July 2015 Pages: 282 - 291

    

13. Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update

    • Kristen B. McCullough
    • Mrinal M. Patnaik

    Myelodysplastic Syndromes (D Steensma, Section Editor) 28 June 2015 Pages: 292 - 302

14. Where Does Lenalidomide Fit in Non-del(5q) MDS?

    • Aristoteles Giagounidis

    Myelodysplastic Syndromes (D Steensma, Section Editor) 14 July 2015 Pages: 303 - 308

    

15. Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?

    • Anna Porwit

    Myelodysplastic Syndromes (D Steensma, Section Editor) 01 July 2015 Pages: 309 - 317

    

16. Outlook and Management of Patients with Myelodysplastic Syndromes Failed by Hypomethylating Agents

    • Daniel A. Roberts
    • David P. Steensma

    Myelodysplastic Syndromes (D Steensma, Section Editor) 01 July 2015 Pages: 318 - 328

17. Preparing Patients With Myelodysplastic Syndrome for Transplant When Is Pre-transplant Cytoreductive Therapy Appropriate?

    • Martin Wermke
    • Silke Gloaguen
    • Uwe Platzbecker

    Myelodysplastic Syndromes (D Steensma, Section Editor) 01 July 2015 Pages: 329 - 333